For many living with diabetes, the routine check-up often centers on managing blood sugar levels, medication regimens, and dietary guidelines. Yet, a critical aspect that frequently goes unaddressed is the health of their eyes, despite the serious risks posed by diabetic complications.

This oversight is precisely what Dr. Matthew Cunningham aims to rectify. A board-certified vitreoretinal specialist, Dr. Cunningham is a partner at the Florida Retina Institute and serves as its Clinical Research Director. Throughout his career, he has dedicated his expertise to treating various retinal diseases, and he is now focusing on raising public and medical awareness regarding Diabetic Macular Edema, or DME.

DME represents a significant, yet often silent, threat to vision among individuals with diabetes. It involves swelling in the macula, the part of the retina responsible for sharp, central vision. If left undetected and untreated, DME can lead to severe and irreversible vision loss.

Dr. Cunningham's initiative, dubbed "All Eyes on DME," seeks to integrate discussions about this particular eye condition more prominently into the broader conversation surrounding diabetes care. His efforts underscore the necessity for diabetic patients and their healthcare providers to prioritize regular eye screenings and proactive management to safeguard vision against this insidious disease.